Free Trial

William Blair Issues Pessimistic Outlook for TCMD Earnings

Tactile Systems Technology logo with Medical background

Tactile Systems Technology, Inc. (NASDAQ:TCMD - Free Report) - Analysts at William Blair decreased their Q1 2025 earnings per share estimates for Tactile Systems Technology in a research report issued on Tuesday, November 5th. William Blair analyst M. Andrew now expects that the company will post earnings of ($0.13) per share for the quarter, down from their previous forecast of ($0.06). The consensus estimate for Tactile Systems Technology's current full-year earnings is $0.71 per share. William Blair also issued estimates for Tactile Systems Technology's Q2 2025 earnings at ($0.19) EPS, Q3 2025 earnings at ($0.28) EPS and FY2025 earnings at $0.81 EPS.

A number of other analysts also recently issued reports on the stock. B. Riley started coverage on shares of Tactile Systems Technology in a report on Thursday, September 26th. They issued a "buy" rating and a $23.00 price target on the stock. StockNews.com upgraded Tactile Systems Technology from a "buy" rating to a "strong-buy" rating in a research report on Friday, September 20th. Oppenheimer lowered Tactile Systems Technology from an "outperform" rating to a "market perform" rating in a research note on Tuesday. Finally, BTIG Research downgraded Tactile Systems Technology from a "buy" rating to a "neutral" rating in a research note on Tuesday.

Check Out Our Latest Report on TCMD

Tactile Systems Technology Price Performance

Shares of Tactile Systems Technology stock traded down $0.24 on Friday, hitting $15.02. 253,782 shares of the company traded hands, compared to its average volume of 245,337. Tactile Systems Technology has a 52 week low of $10.06 and a 52 week high of $16.95. The business has a 50-day simple moving average of $14.13 and a 200 day simple moving average of $13.22. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.89 and a current ratio of 4.37. The stock has a market capitalization of $360.48 million, a P/E ratio of 23.11 and a beta of 1.17.

Tactile Systems Technology (NASDAQ:TCMD - Get Free Report) last posted its quarterly earnings results on Monday, August 5th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.10. Tactile Systems Technology had a return on equity of 9.24% and a net margin of 5.42%. The business had revenue of $73.22 million during the quarter, compared to the consensus estimate of $72.62 million.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Gladius Capital Management LP purchased a new stake in Tactile Systems Technology during the third quarter valued at approximately $44,000. Royce & Associates LP increased its position in shares of Tactile Systems Technology by 2.5% during the 3rd quarter. Royce & Associates LP now owns 612,979 shares of the company's stock valued at $8,956,000 after purchasing an additional 14,780 shares during the last quarter. Victory Capital Management Inc. purchased a new stake in Tactile Systems Technology during the 3rd quarter valued at $180,000. Los Angeles Capital Management LLC lifted its position in Tactile Systems Technology by 36.6% in the third quarter. Los Angeles Capital Management LLC now owns 135,796 shares of the company's stock worth $1,984,000 after buying an additional 36,409 shares during the last quarter. Finally, Arcadia Investment Management Corp MI bought a new stake in Tactile Systems Technology in the third quarter worth $29,000. Hedge funds and other institutional investors own 83.43% of the company's stock.

About Tactile Systems Technology

(Get Free Report)

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.

Featured Articles

Earnings History and Estimates for Tactile Systems Technology (NASDAQ:TCMD)

→ War on Elon Escalates… (From Porter & Company) (Ad)

Should you invest $1,000 in Tactile Systems Technology right now?

Before you consider Tactile Systems Technology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tactile Systems Technology wasn't on the list.

While Tactile Systems Technology currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines